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The Chip/LIM-domain binding protein (LDB)–single-stranded DNA-
binding protein (SSDP) (ChiLS) complex controls numerous cell-fate
decisions in animal cells, by mediating transcription of develop-
mental control genes via remote enhancers. ChiLS is recruited to
these enhancers by lineage-specific LIM-domain proteins that bind
to its Chip/LDB subunit. ChiLS recently emerged as the core mod-
ule of the Wnt enhanceosome, a multiprotein complex that primes
developmental control genes for timely Wnt responses. ChiLS
binds to NPFxD motifs within Pygopus (Pygo) and the Osa/ARID1A
subunit of the BAF chromatin remodeling complex, which could
synergize with LIM proteins in tethering ChiLS to enhancers. Chip/
LDB and SSDP both contain N-terminal dimerization domains that
constitute the bulk of their structured cores. Here, we report the
crystal structures of these dimerization domains, in part aided by
DARPin chaperones. We conducted systematic surface scanning by
structure-designed mutations, followed by in vitro and in vivo
binding assays, to determine conserved surface residues required
for binding between Chip/LDB, SSDP, and Pygo-NPFxD. Based on
this, and on the 4:2 (SSDP-Chip/LDB) stoichiometry of ChiLS, we
derive a highly constrained structural model for this complex,
which adopts a rotationally symmetrical SSDP2-LDB2-SSDP2 archi-
tecture. Integrity of ChiLS is essential for Pygo binding, and our
mutational analysis places the NPFxD pockets on either side of the
Chip/LDB dimer, each flanked by an SSDP dimer. The symmetry
and multivalency of ChiLS underpin its function as an enhancer
module integrating Wnt signals with lineage-specific factors to
operate context-dependent transcriptional switches that are piv-
otal for normal development and cancer.
Wnt enhanceosome | Chip/LDB1-SSDP | Pygo
Vertebrate LIM-domain binding protein 1 (LDB1, also knownas NLI or CLIM) and its Drosophila ortholog Chip have
pleiotropic functions in controlling embryonic and larval devel-
opment at multiple stages (1–4), maintenance of intestinal and
hematopoietic stem cells (5, 6), and differentiation along ery-
throid cell lineages (7, 8). Chip/LDB proteins are recruited to
remote transcriptional enhancers of pivotal developmental con-
trol genes by their C-terminal LIM-interacting domain (LID)
that binds directly to LIM-homeodomain DNA-binding proteins,
or to GATA and basic-loop-helix (bHLH) DNA-binding pro-
teins via LIM-only adaptors. They facilitate communication be-
tween remote enhancers and proximal promoters (2, 9), likely via
looping out intervening sequences (8). These long-range enhancer–
promoter interactions critically depend on, and are mediated by,
self-interaction of LDB proteins (10, 11) through their N-terminal
dimerization domain (DD) (12, 13).
Chip/LDB binds to a single-stranded DNA binding protein
(SSDP, also known as single-stranded binding protein, SSBP)
through the LDB1/Chip conserved domain (LCCD), a short re-
gion downstream of the DD (14, 15). The loss-of-function phe-
notypes of Drosophila chip mutants closely resemble those of ssdp
mutants in various developmental contexts, although the former
tend to be stronger and more pleiotropic than the latter (14, 16),
especially in the early embryo (17). These phenotypic similarities
indicate an intimate cooperation between Chip and SSDP in
mediating enhancer function. Consistent with this, chicken Ssdp1
and Ssdp2 are required to confer transcriptionally active chro-
matin on loci controlled by Ldb1 (15), and murine Ssbp2 is re-
quired for hematopoietic stem cell maintenance, similarly to Lbd1
(18). The molecular basis underlying this intimate cooperation
between Chip/LDB and SSDP is not known.
We recently discovered that Chip/LDB and SSDP form a
stable complex called ChiLS (Chip/LDB-SSDP), which binds to
NPFxD motifs within the nuclear Wnt signaling factor Pygopus
(Pygo) and Osa/ARID1A (17), a chromatin-binding subunit of
the BAF transcriptional coactivator complex (19). The Wnt
enhanceosome is a ChiLS-containing multiprotein complex that
is tethered to Wnt-responsive transcriptional enhancers via T cell
factors/lymphoid-enhancer binding factors (TCF/LEF) and their
associated Groucho/transducin-like enhancer (TLE) corepres-
sors, to prime linked developmental control genes for timely Wnt
responses (17, 20). The Wnt response of this complex is con-
ferred by Pygo, which facilitates loading of the Wnt effector
β-catenin via an adaptor called BCL9, thereby promoting tran-
scriptional activation (ON state) (17, 20), while its rerepression
(OFF state) appears to depend on Osa (21). TheWnt enhanceosome
model envisages a pivotal role of ChiLS in the assembly and
function of the complex, implicating ChiLS as its switch module: Its
chromatin tethering involves a combination of enhancer-associated
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proteins (including LIM proteins, Pygo, TCF/LEF-associated
Groucho/TLE ,and the BAF complex) that determine jointly
the ON and OFF states of Wnt-controlled downstream genes
(17, 20). Importantly, the stoichiometry of the minimal stable
ChiLS complex is 2:4 (Chip/LDB:SSDP), as determined by size-
exclusion chromatography followed by multiangle light-scattering
(SEC-MALS) of purified recombinant proteins (17), implying that
ChiLS contains 1 Chip/LDB dimer and 2 SSDP dimers.
Here, we report the crystal structures of the DD of SSDP and
XLdb1, in the latter case with the help of DARPin (designed
ankyrin repeat proteins) chaperones that mask a hydrophobic
surface patch of the DD required for its SSDP binding. Sys-
tematic structure-led mutagenesis of conserved solvent-exposed
residues of Chip/LDB and SSDP followed by in vitro and in vivo
binding assays enabled us to generate an interaction map, and to
derive a highly constrained structural model for ChiLS. Its
rotationally symmetric SSDP2-LDB2-SSDP2 architecture with 2
predicted NPFxD-binding pockets on either side underscores its
function as an integrating core module of the Wnt enhance-
osome and other ChiLS-containing enhancer-binding complexes.
Results
SSDP contains an N-terminal LisH domain known to form ob-
ligate dimers in other proteins (22), followed by a highly con-
served extension and a long nonconserved C-terminal tail likely
to be disordered (Fig. 1A). The extended N-terminal dimeriza-
tion domain (called SSDP-N below; also known as the LUFS
domain) (14) can form stable tetramers in vitro following bac-
terial expression (17). To determine the structure of SSDP-N, we
optimized its boundaries and succeeded in obtaining crystals for
SSDP1–86 that diffracted to 2.4 Å. As we were unable to use
molecular replacement with the LisH domain as a search model,
we generated 5 different selenomethionine (SeMet)-labeled mutants,
1 of which yielded diffracting crystals that enabled us to determine
the structure of SSDP-N (SI Appendix, Table S1).
Structure of the SSDP-N Dimer. The asymmetric crystallographic
unit contains a classic LisH dimer-fold in which 2 α-helices (α1,
α2) (Fig. 1B) associate to form an antiparallel 4-helix bundle
(22), the hydrophobic interface of which is strengthened by ad-
ditional hydrogen bonds in its periphery (Fig. 1C). A third helix
(α3) interacts with its counterpart (α3′) from the opposite dimer
to form an X-shaped structure, tucked under the 4-helix bundle.
It thus resembles TBL1, a subunit of a transcriptional co-
repressor complex and the only other LisH-containing protein
known to form tetramers (23), except that the lengths and angles
between α3 and α3′ differ in the 2 structures (SI Appendix, Fig.
S1). As in other LisH dimers, the dimer interface is extensive
(burying ∼2,500 Å2), which explains why SSDP forms obligate
dimers, and why SSDP monomers are not detectable (17) (see
also below). Indeed, the Kd for LisH-mediated self-association of
Lis1 was reported to be subfemtomolar (22).
Within the crystal lattice, symmetry-related dimers associate
via 2 perpendicular pairs of antiparallel α3 helices. The resulting
interlocked bundle of 4 α-helices bury ∼1,400 Å2 (Fig. 2A), and is
held together entirely via hydrophobic contacts, with valine 65
(V65) occupying a central position in the tetramer interface (“α3
interface,” below). The same tetramer was observed for human
SSBP2 (whose structured region differs from fly SSDP-N only by
2 semiconserved residues) (Fig. 1B) (24) whose structure was
reported during the final stages of our work. Intriguingly, some
of the hydrophobic residues in the loop between α2 and α3 also
mediate association between symmetry-related dimers in the
crystal, resulting in alternative tetramer configurations (Fig. 2B).
Although these loop-mediated interactions bury smaller inter-
faces (602 Å2 and 624 Å2, respectively; ”loop interface,” below),
they proved to be functionally relevant in vivo (see below). We
Fig. 1. Structure of the SSDP dimer. (A) Cartoons of SSDP and Chip/LDB and their domains (numbers, Drosophila SSDP and Chip). (B) Sequence alignment of
the N-terminal dimerization domain of Drosophila (Dm), human (Hs), and Trichoplax adhaerens (Ta) SSDP, with secondary elements indicated above; bold
indicates amino acid variations between Hs SSBP2 and Dm SSDP (structured region only); colored indicates crucial mutated residues. (C) Ribbon represen-
tations of SSDP dimer, with helices labeled; (Left Inset) dimerization interface between α2 and α2′, with key residues shown in stick, and hydrogen bonds
(between α2′ E43 and main chain α2 atoms) as yellow dashed lines; (Right Inset) α3/α3′ dimerization interface, with key hydrophobic residues shown in stick.
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note that TBL1 tetramerizes via α2 (SI Appendix, Fig. S1) via
residues that are not conserved in SSDP.
Alternative Modes of Self-Interaction of SSDP Dimers. To test the
functional relevance of the different modes of SSDP self-interactions,
we designed repelling amino acid substitutions in solvent-exposed
hydrophobic residues in the 2 alternative interfaces of SSDP-N,
mutating a centrally located valine in the α3 interface (V65K), and
2 hydrophobic residues in the loop interface (I50E L52E, called
ML) that mediate mutual interactions in the crystals (Fig. 1B). We
also included a previously designed triple mutation of hydropho-
bic residues flanking V65 (F66E L69A Y70A, called Mα3) that
blocks SSBP2-N tetramerization (24). These mutations were in-
troduced into Lip-SSDP1–92 and their self-interaction was tested
by SEC-MALS. As expected (24), Mα3 blocks tetramerization of
SSDP-N, but V65K does not (Fig. 2C), likely because this single
mutation is too weak to do so, given the extensive α3 interface.
ML also reduces tetramerization of SSDP-N significantly (Fig.
2C). We conclude that both modes of SSDP-N tetramerization
can occur, with α3 being the preferred interface. Tetramerization
likely occurs during bacterial expression since SSDP-N dimers and
tetramers are stable in solution for >8 h, and do not interconvert
following purification.
Next, we designed another 16 substitutions in conserved solvent-
exposed residues that should not perturb the fold of SSDP-N (SI
Appendix, Fig. S2A), and introduced these (plus V65K) into full-
length V5-tagged SSDP. We then coexpressed these with WT
FLAG-tagged SSDP in HEK293T cells from which we deleted
LDB1 and LDB2 by CRISPR engineering (below, double-knockout
[DKO] cells) (SI Appendix, Fig. S3), to test their mutual associ-
ation by coimmunoprecipitation (co-IP) in the absence of en-
dogenous LDB. As expected, SSDP-FLAG co-IPs efficiently
with WT and most mutant SSDP-V5, except for I50E, L52E,
P55E, and F58E (each altering the loop surface) (Fig. 2B and SI
Appendix, Fig. S2A), which do not coimmunoprecipitate at all.
Mα3 produces a reduced co-IP signal, partly because this triple-
mutant is somewhat unstable in cells (Fig. 2D and SI Appendix,
Fig. S2B). We conclude that full-length SSDP dimers also self-
associate in cells upon overexpression, but do so entirely through
their loop interface. This implies that the SSDP C terminus
blocks self-association of full-length SSDP via its α3 surface.
Structure of the LDB Dimer. Next, we purified fragments spanning
the DD or DD-LCCD from human LDB1, linked to a cleavable
His6 and Lipoyl (Lip) tag, but could not crystallize these.
Screening LDB orthologs from different species, we found that
Xenopus laevis Ldb1 (XLdb1) (1) yielded the most stable protein
after removal of solubility tags. XLdb1 is closely related to hu-
man LDB1 (SI Appendix, Fig. S4), but we did not succeed in
obtaining diffracting crystals with this protein either, largely
because the DD and DD-LCCD undergo nonspecific aggrega-
tion over time. We therefore resorted to chaperone-based ap-
proaches, selecting nanobodies (25) or high-affinity DARPins,
genetically engineered antibody-mimetics based on consensus
ankyrin repeat proteins and selected from diverse synthetic libraries
(26), against the purified DD or ChiLS complex (SI Appendix,
Supplementary Methods). None of 35 selected nanobodies facili-
tated crystallization, but we obtained DD crystals with 5 of 15 se-
lected DARPins (SI Appendix, Fig. S5) that diffracted to 2.0 to 2.59 Å
(SI Appendix, Table S1), depending on the DARPin (SI Appen-
dix, Fig. S6A). None of these 5 DARPins bind to the DD-LCCD
nor to the assembled ChiLS complex.
Next, we determined the crystal structures of the DD (XLdb1
20-200) bound to DARPin2, -3, -5, -7, or -10 (SI Appendix, Fig.
S6). Remarkably, each of the 5 DARPins (despite their different
sequences) recognizes the same lateral surface patch of the DD,
perpendicular to its dimerization interface and facing outwards
(SI Appendix, Fig. S6B). This patch is highly hydrophobic (e.g.,
Y81, I83, and L87 engage in direct DARPin contacts), which ex-
plains why its masking by DARPins was crucial to prevent non-
specific aggregation of the DD via this patch (called “hydrophobic
patch,” below).
The DD adopts a cone-shaped α+β barrel-fold, composed of a
long, highly curved antiparallel β-sheet (formed by β1 to 6)
whose cavity is filled by 3 α-helices (α1 to α3) that run roughly
parallel to the β-sheet (Fig. 3A). This structure is capped by a
Fig. 2. Two modes of SSDP tetramerization. (A and B) Tetramerization of
SSDP through (A) α3 interface or (B) loop interface (between α2 and α3),
with key mutated residues in stick (same color in all panels). (C) SEC-MALS
profiles of WT and selected Lip-SSDP1–92 mutants, as indicated; numbers in
Upper, Mr determined by MALS (corresponding to SSDP2 and SSDP4; expec-
ted Mr, 47 and 94 kDa, respectively). (D) co-IP assays of selected SSDP mutants
in transfected LDB1/2 DKO cells (see also SI Appendix, Figs. S2 and S3).
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short C-terminal extension at the apex of the DD, formed by 2
intertwined α-helices (α4 and α5) that contribute to the dimer in-
terface (Fig. 3B). The whole dimer interface is extensive (burying
∼1,500 Å2), which explains why the DD dimer is highly stable in
solution.
Curiously, the closest structural relative of the DD is scytalone
dehydratase (27) (rmsd ∼2 Å), a bacterial ketosteroid isomerase (SI
Appendix, Fig. S7A). The DD also resembles the fold of other
members of this enzyme family (28), which are among the most
efficient enzymes known (29). The DD fold is also found in eu-
karyotes; for example, in nuclear transport factor-2 (NTF-2) (30)
(rmsd ∼2.2 Å) (Fig. 3C). Whether any of these structural similari-
ties have functional significance is unclear. The oligomeric state of
the DD folds is variable, ranging from monomeric to tetrameric,
and their dimerization modes also vary, with some folds dimerizing
via their curved β-sheets (SI Appendix, Fig. S7B). However, none of
the known DD folds contain an intertwined apical extension, as
seen in the XLdb1 DD (Fig. 3B and SI Appendix, Fig. S7B). This
apex may help to determine the dimerization mode of the DD, and
stabilize the Chip/LDB dimer, given that a region spanning this
apex is essential for β-globin transcription during erythroid matu-
ration (albeit not for LDB1 dimerization per se, as the DD core
may be partially competent to dimerize by itself) (11).
Binding Between Chip/LDB and SSDP. Next, we attempted to crys-
tallize the ChiLS complex, using bicistronic coexpression of
SSDP1–92 and DD-LCCD from XLdb1. LCCD is a conserved 49-
amino acid stretch (Fig. 1A and SI Appendix, Fig. S4) required
for binding to SSDP (14, 15). It spans 2 predicted α-helices (α6
and α7), whereby α6 is separated from the DD by a linker of 9
conserved residues (SI Appendix, Fig. S4). We designed 2 DD
fragments with C-terminal extensions, namely DD-LCCD1 (20-
244, spanning α6 and α7) or DD-LCCD2 (20-226, spanning only
α6). Both form a stable complex with SSDP1–92, implying that α6
suffices for SSDP binding at high protein concentrations during
bacterial expression. We purified both complexes, but did not
obtain diffracting crystals despite testing a wide range of condi-
tions, as well as cocrystallization with nanobodies or DARPins.
We therefore took an alternative approach, namely systematic
mutational analysis of conserved solvent-exposed residues of
each ChiLS dimer subunit (Fig. 4A), to identify their surfaces
required for mutual interaction. Since DARPin binding to their
cognate patch of the DD (Fig. 3B) blocks its interaction with
SSDP, we initially focused on this hydrophobic patch, designing
a set of repelling mutations (SI Appendix, Fig. S8), which might
block binding between DD-LCCD1 and SSDP. Indeed, 2 of
them do so (L87D R90D and Y81D L87D R90D) (SI Appendix,
Table S2). Since Y81, L87, and R90 are direct DARPin-interacting
Fig. 3. Structure of the DD. (A and B) Ribbon representations of (A) the DD monomer (with α-helices labeled) and (B) the DD dimer; vertical line is the
symmetry axis; blue is the DARPin-binding patch. (C) Superimposition of the DD (wheat) and NTF2 (green; 1JB5) (see also SI Appendix, Fig. S7).
Fig. 4. Mutual interactions between Chip/LDB, SSDP, and Pygo. (A) Func-
tionally relevant solvent-exposed residues in the DD (Chip residue numbers
in parenthesis), tested for interaction with SSDP and Pygo. (B) Surface rep-
resentation of DD, with hydrophobic patch mediating interaction with SSDP
highlighted; Y81, L87, and R90, DARPin-binding residues; C197 marks the C
terminus of the structured part of the DD, and start of LCCD. (C) co-IP assays of
selected mutants in transfected HEK293T cells (see also SI Appendix, Table S3).
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residues (Fig. 4B), this implicates the hydrophobic patch in the
interaction between SSDP and the DD.
Next, we designed additional mutations in the apical, lateral,
and basal surfaces of the DD dimer, in LCCD and its linker to
DD (SI Appendix, Fig. S8), and we also generated internal de-
letions that remove LCCD α6 or α7 (Δα6, Δα7), for co-IP assays
in transfected HEK293T cells aimed at testing the binding between
full-length proteins. To minimize cross-reaction with endogenous
LDB, we introduced these mutations into Chip-V5FLAG, and
coexpressed them with SSDP-V5. This confirmed the functional
importance of Y81, L87, and R90, but also identified additional
residues near the hydrophobic patch as critical for co-IP with SSDP
(Fig. 4C and SI Appendix, Table S3), marking a contiguous hy-
drophobic surface in the DD (Fig. 4B). In contrast, repelling point
mutations in the apical or basal surface of the DD did not affect
co-IP between Chip and SSDP (SI Appendix, Table S3). We con-
clude that a lateral hydrophobic surface patch of the DD is crucial
for its association with SSDP. This implies that a single Chip/LDB
dimer can accommodate 2 SSDP dimers.
In addition to this hydrophobic patch, we also found that α6 is
crucial for co-IP between Chip and SSDP, while Δα7 also re-
duces it; indeed, mutation of a single methionine in α6 (M406R)
reduces co-IP between the 2 proteins to background levels (Fig.
4C). M402E also blocks co-IP, and L405D reduces it, as does a
double mutation in α7; however, none of the mutations in the
conserved linker between the DD and LCCD affect co-IP (SI
Appendix, Table S3). Thus, α6 is essential for binding between
Chip and SSDP, and M402 and M406 may directly contact SSDP.
Consistent with this, a 10-amino acid stretch spanning these me-
thionines in Chip is essential for its binding to SSDP (14), as is a
similar 6-amino acid stretch in chicken Ldb1, whereby the latter is
also critical for motoneuron specification in the chicken embryo
(15), indicating the physiological importance of LCCD α6. Either
α6 constitutes the SSDP-binding surface of Chip/LDB, together
with the lateral hydrophobic patch, or this patch binds primarily to
α6, which in turn binds to SSDP, perhaps the more likely scenario,
for reasons discussed below. In contrast, α7 appears to be auxiliary
in mediating the Chip/LDB-SSDP interaction.
To define the Chip-binding surface of SSDP, we conducted
co-IP assays between WT Chip-V5FLAG and our panel of 17
SSDP-V5 mutants (Fig. 2D and SI Appendix, Fig. S2A), following
coexpression in HEK293T cells. Most SSDP mutations have no
effect (including ML), but D68R reduces co-IP, as does Mα3,
while V65K essentially blocks co-IP (Fig. 4C). We conclude that
SSDP binds to Chip/LDB via its α3 surface (Fig. 2A).
Dependence of Pygo Binding on ChiLS Complex Assembly. Next, we
tested our SSDP and Chip mutants for interaction with Drosophila
Pygo upon coexpression in HEK293T cells. This interaction is
relatively weak, and not easily detectable by co-IP (17). However,
we consistently obtained a co-IP signal between Pygo and WT
Chip and SSDP, but with none of the mutants that block the Chip–
SSDP interaction (Fig. 4C and SI Appendix, Table S3). This sug-
gests that the integrity of the ChiLS complex is essential for Pygo
binding, consistent with our previous evidence that peptides
spanning NPFxD from Pygo or human Pygo2 bind to the assem-
bled recombinant ChiLS complex but not to its subunits alone
(17). Notably, F58E blocks Pygo binding to ChiLS while it barely
affects binding between Chip and SSDP, which suggests that SSDP
F58 contributes critically to the NPFxD-binding pocket of ChiLS.
To corroborate our co-IP results with in vitro binding assays
between recombinant proteins, we used NMR spectroscopy (17),
probing an 15N-labeled 27 amino acid peptide spanning NPFED
from human Pygo2 (15N-Lip-NPFEDPygo2) with purified recombinant
ChiLS. This revealed that WT ChiLS interacts with 15N-Lip-
NPFEDPygo2, even without LCCD α7 (SI Appendix, Fig. S9), in-
dicating that the latter is dispensable for ChiLS binding to NPFxD
at high protein concentration. We also used this assay to determine
whether excess unlabeled Lip-NPFDD peptide from Pygo can
compete for binding of purified ChiLS to an 15N-labeled 26
amino acid peptide from Osa (15N-Lip-NPFEDOsa), which was the
case (SI Appendix, Fig. S10). This implies that the same ChiLS
pocket can accommodate the NPFxD motif of either ChiLS ligand.
A Highly Constrained Structural Model of ChiLS. Next, we con-
structed a model of the ChiLS complex, taking into account its
constituent dimer structures (Figs. 1C and 3B), the results from
our mutational analysis (Fig. 4 and SI Appendix, Tables S2 and
S3) and the previously determined 4:2 (SSDP:Chip/LDB) stoi-
chiometry of the ChiLS complex (17). The only ChiLS configu-
ration that is consistent with all our data corresponds to an
SSDP2-LDB2-SSDP2 architecture with rotational symmetry (Fig.
5A). In this model, the lateral hydrophobic surface patches of
each DD subunit (Fig. 5A, blue) interface with their downstream-
adjacent LCCD α6 (Fig. 5A, orange) and the α3 surface of an
SSDP dimer (Fig. 5A, dark cyan). Because of its inherent rota-
tional symmetry, the complex can accommodate two NPFxD li-
gands (Fig. 5A, gray rods), through opposite pockets whose
positions are defined by proximity to the LCCD α6 methionines
(Fig. 5A, orange sticks) and SSDP F58 (Fig. 5A, red patch).
To corroborate our model, we asked whether a minimal
LCCD fragment could bind SSDP, and if so, whether this would
be sensitive to mutations in its α3 or loop surface. We therefore
conducted SEC-MALS of Chip-LCCD (residues 384 to 436, of
which 47 are identical in human LDB1) (SI Appendix, Fig. S4)
tagged with maltose binding protein (MBP) coexpressed with
WT, V65K, Mα3, or ML Lip-SSDP1–92. As a further control, we
also included a triple mutant of LCCD (M402E L405D M406R,
Mα6) expected to block binding to SSDP (Fig. 4C). Indeed, the
WT proteins form predominantly a single complex eluting in 1
main SEC peak, containing similar amounts of LCCD and SSDP
as judged by PAGE of the corresponding fractions (Fig. 5B).
Based on its molar mass (Mr = 190 kDa) as determined by
MALS, the complex in this peak most likely corresponds to
LCCD-SSDP4-LCCD: That is, 2 LCCD-SSDP2 complexes
interacting via the SSDP loop interface (Fig. 5B, cartoon). We
also observed a smaller peak (Mr = 90 kDa), likely corre-
sponding to LCCD-SSDP2, in addition to minor peaks with
considerably higher molar masses, likely corresponding to un-
specific aggregates (Fig. 5B, asterisks). As expected, none of the
mutants show the 190-kDa complex: SSDP Mα3 neither binds to
LCCD nor tetramerizes, and so only forms dimers; SSDP V65K
and LCCDMα6 cannot bind to their partner subunits, and so the
2 main peaks observed with these mutants correspond to LCCD
and SSDP4 (Fig. 5B, cartoons). Importantly, SSDP ML can in-
teract with LCCD through α3, and so forms LCCD-SSDP2
(possibly in addition to coeluting SSDP4) (Fig. 5B). This con-
firms that 1) LCCD can bind to SSDP directly via α6, and 2)
SSDP dimers can undergo mutual interactions via their loop
surfaces if bound to LCCD. Thus, in the presence of LCCD, the
α3 surface of SSDP prefers to bind to LCCD rather than itself.
Discussion
Our work has led to a highly constrained structural model of ChiLS,
the core complex of the Wnt enhanceosome (17, 20). Its rotational
symmetry implies that ChiLS contains 2 structurally identical NPFxD-
binding pockets, each bordered by an SSDP dimer and LCCD α6
(and possibly DD residues) (Fig. 5A), and each binding either Pygo2
or Osa NPFxD (SI Appendix, Fig. S10). Thus, 1 single ChiLS core
complex, via its 2 NPFxD pockets, could accommodate Pygo as well
as the Osa/ARID1 subunit of the BAF complex simultaneously.
This is consistent with the notion that Pygo and the BAF complex
are constitutive components of the Wnt enhanceosome (20).
ChiLS is also found in other enhancer-binding complexes,
most notably those binding to the remote LCR enhancer that
controls β-globin genes during erythroid maturation (8, 18, 31),
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but also to transcriptional enhancers of developmental control
genes (1–4), and of genes that control stem cell maintenance (5,
6) and normal as well as malignant erythroid differentiation (7,
32, 33). N-terminal domains of Chip/LDB proteins self-associate
(12, 13), and this property is crucial for mediating long-range
interactions between remote enhancers and proximal pro-
moters (2, 8, 10, 11). The DD dimer, as revealed by our struc-
tural analysis (Fig. 3B), provides the molecular basis for this
function of Chip/LDB in mediating long-range enhancer–
promoter interactions. From its structure, it is difficult to see how
DD could oligomerize, as previously proposed (2, 8, 13), but we
note that recombinant DD has a tendency aggregate in vitro, likely
via its hydrophobic DARPin-binding patch.
Recombinant SSDP-N clearly tetramerizes via its α3 surface
(24) (Fig. 2 A and C). However, in our co-IP assays involving
expression of full-length proteins in cells, SSDP uses its α3 sur-
face exclusively for Chip/LDB binding, while it self-associates via
its loop surface (Fig. 2C). Furthermore, our evidence suggests
that LCCD binding to SSDP may promote loop-mediated self-
association of SSDP (Fig. 5B), possibly by inducing a confor-
mational change of its loop surface. Indeed, Chip/LDB-bound
SSDP dimers that self-associate via their loop interfaces (Fig. 2
B–D) could promote dimerization of the core ChiLS complex
(Fig. 5B), assembling higher-order oligomers that could be in-
strumental for the function of ChiLS in mediating long-range
enhancer–promoter contacts. Whatever the case, our results
strongly support the notion that SSDP is essential for the function
of Chip/LDB proteins in transcriptional activation by remote en-
hancers (14, 17, 18, 31, 34, 35).
Our structural model of ChiLS provides mechanistic insight
into how ChiLS-containing enhancer complexes integrate mul-
tiple inputs from signaling and lineage factors: Because of its
symmetrical SSDP2-Chip/LDB2-SSDP2 architecture, a single ChiLS
core complex can bind simultaneously to 2 different NPFxD ligands
(17, 20) (Fig. 5A) and to 2 sets of distinct enhancer-binding proteins
via its LID (binding to LIM-containing proteins, or GATA and
bHLH factors) (3, 4, 7, 8). Therefore, ChiLS is uniquely poised as
an integrating core module of multiprotein complexes that are
tethered to transcriptional enhancers by specific combinations of
DNA-binding proteins and their associated signal-responsive co-
factors. Furthermore, by exchanging some of these factors, ChiLS
can switch enhancer complexes between ON and OFF states.
Materials and Methods
Plasmids. Plasmids used for cell-based assays and bacterial expression were
used as described previously (17), including His8 (for DARPins), His6-Lip (for
XLdb1 and SSDP mutants), and bicistronic expression vectors (for coex-
pression of SSDP1–92 and MBP-LCCD).
Protein Purification. Proteins were expressed in BL21(DE3)-RIL, and purified
with Ni-NTA resin followed by gel filtration. For crystallization, the solubility
tags were removed by gel filtration following digestion with tobacco etch
virus protease.
Functional Assays in Human Cells. HEK293T cells were grown in DMEM, sup-
plemented with 10% FBS and transfected in 6-well plates with PEI. One-
hundred nanograms per well of Chip, 400 ng per well of SSDP, and 500 ng
per well of Pygo constructs were used for all transfections.
DARPin Selection. Ribosome display selections against the DD or ChiLS complex
were carried out as detailed in SI Appendix, Supplementary Methods.
NMR Spectroscopy. Proteins were expressed in minimal medium supple-
mented by 15N-ammonium chloride and purified as described above. NMR
Fig. 5. Structural model of the ChiLS complex. (A) Structural model of ChiLS,
derived from stoichiometry of complex and mutational analysis (see text);
(Upper) side view; (Lower) view from top, revealing rotational symmetry of
ChiLS and its binding sites for SSDP and NPFxD (whose precise positions and
angles relative to the DD are arbitrary in this model). SSDP dimers (cyan)
were docked manually onto the DARPin-binding patch (blue) in each lateral
surface of the DD (wheat); (orange) predicted LCCD α6, with SSDP-binding
residues (M402, M406) in stick; positions of the pockets for NPFxD (gray
rods) are restrained by proximity to LCCD α6 (orange) and SSDP F58 (red);
note that SSDP′ F58 (gray) differs from SSDP F58 (red) regarding its struc-
tural environment. (B) SEC-MALS profiles of complexes (cartoons above
panels) formed between coexpressed WT and mutant MBP-LCCDChip and
Lip-SSDP1–92; numbers are Mr values determined by MALS (within panels), or
as expected (above panels); asterisks are large aggregates; below, PAGE
revealing proteins in corresponding preparative SEC fractions.
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spectra were recorded with a Bruker Avance III spectrometer at 600 MHz 1H,
as described previously (17).
SEC-MALS. Purified proteins were analyzed with an Agilent 1200 Series
chromatography system connected to a DawnHeleos II 18-angle light-scattering
detector combined with an Optilab rEX differential refractometer (Wyatt).
Samples were loaded onto a Superdex-200 10/300 gel-filtration column (GE
Healthcare) at 2 mg/mL and run at 0.5 mL/min in buffer (PBS, 1 mM DTT). Data
were processed with Astra V software.
Crystallization. Concentrated proteins (10 to 20 mg/mL) were used for initial
screens with ∼1,500 different crystallization conditions in 100 + 100-nL drops
in a 96-well sitting-drop format. Crystals emerged under multiple conditions
(SI Appendix, Table S1) after growing for several days at 19 °C by the vapor-
diffusion method, and were directly flash-frozen in liquid nitrogen. For
determination of structures, see SI Appendix, Supplementary Methods.
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